Vetmab Biosciences files Form D for equity offering worth nearly $12 million
The San Diego biotechnology company disclosed it has sold most of an equity offering under Regulation D, with about $505,000 left to sell.
SEC filing
Latest
1 story
Sign inSign in1 story
The San Diego biotechnology company disclosed it has sold most of an equity offering under Regulation D, with about $505,000 left to sell.
SEC filing